Wave Life Sciences
144 hedge funds and large institutions have $474M invested in Wave Life Sciences in 2024 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 47 increasing their positions, 45 reducing their positions, and 23 closing their positions.
57% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 23
9% more funds holding
Funds holding: 132 → 144 (+12)
1.76% more ownership
Funds ownership: 75.86% → 77.62% (+1.8%)
4% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 45
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
17% less capital invested
Capital invested by funds: $572M → $474M (-$97.9M)
49% less call options, than puts
Call options by funds: $165K | Put options by funds: $325K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$14.2M |
| 2 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$10.4M |
| 3 |
State Street
Boston,
Massachusetts
|
+$4.27M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.33M |
| 5 |
AG
Artal Group
Luxembourg
|
+$2.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$10.6M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$5.85M |
| 3 |
MCM
M28 Capital Management
Stamford,
Connecticut
|
-$4.77M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.47M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.41M |
WVE Hedge Fund Activity: Q2 2024 in Review
144 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q2 2024, worth a combined $474M — down 17% from $572M a quarter earlier.
Buyers outnumbered sellers: 36 funds opened new WVE positions and 23 closed out — a net gain of 13 holders — while 47 added to existing stakes and 45 trimmed.
The largest buyer was Emerald Advisers, opening a new position worth an estimated $14.2M. The largest seller was Point72 Asset Management, cutting an estimated $10.6M.
- 144 institutional investors held Wave Life Sciences (WVE) as of Q2 2024, up from 132 in Q1 2024.
- Funds reported $474M of Wave Life Sciences stock for Q2 2024, down 17% quarter-over-quarter.
- 36 funds opened new Wave Life Sciences positions in Q2 2024 and 23 closed out, a net change of +13 holders.
- The largest Wave Life Sciences buyer in Q2 2024 was Emerald Advisers, an estimated $14.2M added.
- The largest Wave Life Sciences seller in Q2 2024 was Point72 Asset Management, an estimated $10.6M sold.
Based on aggregated 13F filings for Q2 2024.